SEC Form 4/A · accession 0001104659-16-091217
Vitae Pharmaceuticals, Inc · VTAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Richard Gregg
Officer — Chief Scientific Officer
Period of report
Nov 13, 2015
Accepted (ET)
Jan 25, 2016 · 5:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157602
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 16, 2015 | M | 15,000 | $3.91 | A | 102,272 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The original Form 4, filed on November 17, 2015, did not include an acquisition of 1,715 shares of Common Stock by the Report Person pursuant to the Vitae Pharmaceuticals, Inc. 2014 Employee Stock Purchase Plan.